About | Free Trial

Last Update

2015-10-21T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Curtis Cooper?

Dr. Curtis Cooper L.

Associate Professor of Medicine

University of Ottawa

Direct Phone: (613) ***-****       

University of Ottawa

451 Smyth Rd. Room 2033

Ottawa, Ontario K1H 8M5

Canada

Company Description

Located in the heart of the nation's capital, the University of Ottawa is one of Canada's principal comprehensive, research-intensive, postsecondary institutions. Its campus community totals more than 40,000 full-time students, faculty and staff living, w ... more

Find other employees at this company (12,969)

Background Information

Employment History

Co-Chair
Concurrent Diseases Research Core

Co-Chair
CIHR Canadian HIV Trials Network Co-infection

Clinical Sciences Track Co-Chair
Canadian Association for HIV Research

Scientific Steering Committee Member
Ontario HIV Treatment Network

Affiliations

Executive Board Member
Canadian Association of HIV Researchers

Education

MD

MD

University of Saskatchewan

medical degree

University of Saskatchewan

Web References (133 Total References)


infohep - Interferon-free hepatitis treatment is highly effective for people with HIV and HCV co-infection in three studies

www.infohep.org, $reference.date [cached]

Curtis Cooper of the University of Ottawa presented findings from ION-4, a phase 3 trial evaluating the safety and efficacy of Gilead Science's nucleotide HCV polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir - the drugs in the Harvoni coformulation - for people with HIV and HCV co-infection.

...
Dr Cooper explained that historically, when using interferon, unless a person had a CD4 count over 500 cells/mm 3 it was considered best to treat HIV first and get that virus under control and CD4 cell count up before starting hepatitis C treatment. But these days, with well-tolerated short-duration hepatitis C therapy, "there's a lot to be said for offering [hepatitis C] treatment to people with lower CD4 counts," he said.


Curtis Cooper of the ...

www.infohep.org, $reference.date [cached]

Curtis Cooper of the University of Ottawa presented findings from ION-4, a phase 3 trial evaluating the safety and efficacy of Gilead Science's nucleotide HCV polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir - the drugs in the Harvoni coformulation - for people with HIV and HCV co-infection.

...
Dr Cooper explained that historically, when using interferon, unless a person had a CD4 count over 500 cells/mm 3 it was considered best to treat HIV first and get that virus under control and CD4 cell count up before starting hepatitis C treatment. But these days, with well-tolerated short-duration hepatitis C therapy, "there's a lot to be said for offering [hepatitis C] treatment to people with lower CD4 counts," he said.


Dr. Curtis L. Cooper ...

www.researchid.com, $reference.date [cached]

Dr. Curtis L. Cooper (University of Ottawa)


Curtis Cooper, MD, ...

www.newevidence.ca, $reference.date [cached]

Curtis Cooper, MD, FRCPC

Dr. Cooper trained at the University of Saskatchewan, receiving his medical degree in 1994. He received certifications in Internal Medicine in 1997 and in Infectious Diseases in 1999 while at the University of Manitoba. He completed an HIV Research Fellowship and a master's degree in Epidemiology in 2002 at the University of Ottawa.
Dr. Cooper's current titles include Associate Professor with the University of Ottawa, Scientist with the Ottawa Hospital Research Institute, Infectious Diseases Consultant with the Ottawa Hospital Division of Infectious Diseases, and Director of The Ottawa Hospital Viral Hepatitis Program, and he holds an Applied HIV Research Chair with the Ontario HIV Treatment Network (OHTN). Dr. Cooper is also co-chair of the CIHR Canadian HIV Trials Network Co-infection and Concurrent Diseases Research Core and an executive board member of the Canadian Association of HIV Researchers.


Dr. Curtis Cooper, MD, ...

cfenet.ubc.ca, $reference.date [cached]

Dr. Curtis Cooper, MD, FRCPC Associate Professor of Medicine- University of Ottawa The Ottawa Hospital- Division of Infectious Diseases Email: ccooper@toh.on.ca

Similar Profiles

Other People with this Name (119,748)

Other people with the name Cooper

Margaret Cooper
University of Surrey

Dusty Cooper
Church of Christ

Andrew Cooper
Pegasus Capital Advisors , L.P.

Mason Cooper

Constance Cooper
University of Cincinnati

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory